Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYae Wei Xuen_US
dc.contributor.authorYi Dong Weien_US
dc.contributor.authorKai Tangen_US
dc.contributor.authorYan Qing Chenen_US
dc.contributor.authorWei Ming Lien_US
dc.contributor.authorXue Jing Yuen_US
dc.contributor.authorYong Wen Qinen_US
dc.contributor.authorGou Xian Qien_US
dc.contributor.authorPeng Quen_US
dc.contributor.authorYu Qing Houen_US
dc.contributor.authorAshok Jainen_US
dc.contributor.authorParvez Granten_US
dc.contributor.authorGudapati Rameshen_US
dc.contributor.authorBasavappa Rameshen_US
dc.contributor.authorChumpol Piamsomboonen_US
dc.contributor.authorSrun Kuanpraserten_US
dc.contributor.authorHyeon Cheol Gwonen_US
dc.contributor.authorYoon Haeng Choen_US
dc.contributor.authorHaizal Haroon Kamaren_US
dc.contributor.authorCong Xin Huangen_US
dc.description.abstractBackground: Recent studies have showed that the fine mesh stents are associated with a significant reduction in both clinical and angiographic re-stenosis of the coronary arteries. To maintain a very satisfactory radio-opacity using the stents, Guidant of the USA has designed a new type of bare metal stents (BMS)-Multi-link (ML) Vision/ML MiniVision stents. The clinical outcomes of Asian patients with coronary artery disease (CAD) after implanting the Multi-link Vision or MiniVision stent were investigated in this study. Methods: An observational, prospective, multi-center, non-randomized post marketing registry was conducted to demonstrate the efficacy of the BMS-ML Vision/ML MiniVision stents. The primary end point of the registry was clinical target lesion revascularization (TLR) at a 6-month follow-up. The major secondary end points included the rate of major adverse cardiac events (MACE) and serious adverse events (SAE) in hospital and at 6 months; and the rate of clinical TLR as a function of the type of angina. A total of 429 Asian people with 449 lesions from 14 centers were selected for this study. The average reference diameter of the lesions was (3.0±0.5) mm, and the mean length was (15.7±5.0) mm. Results: The successful rate of the procedure was 99.3%. Twenty-five percent of the lesions were treated by direct stenting without pre-dilation. Eighty-six percent of the lesions were implanted with ML Vision stent. After the 6-month follow-up, the rate of clinical TLR was 1.4%. The MACE, SAE and target vessel revascularization (TVR) were 6.8%, 3.5% and 1.4% respectively. Conclusion: The current registry showed the excellent 6-month clinical outcomes of ML Vision/ML MiniVision stents in Asian patients with CAD.en_US
dc.titleMulti-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: A prospective, multi-center studyen_US
article.title.sourcetitleChinese Medical Journalen_US
article.volume120en_US General Hospitalen_US Universityen_US Hospitalen_US Medical University Shenyangen_US Medical Universityen_US Hospitalen_US Hall Clinicen_US Mullapudi Cardiac Centeren_US Jayadeva Institute of Cardiologyen_US College of Medicineen_US Mai Universityen_US Medical Center, Sungkyunkwan Universityen_US Universityen_US of Malaya Medical Centreen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.